SAN DIEGO — Ozanimod was associated with stable or improved cognition in nearly 90% of patients who received the drug for relapsing-remitting multiple sclerosis (RRMS), a new study showed. Results ...
A systematic review finds that diagnostic discordance in bone and soft tissue sarcoma may reduce survival, supporting expert second opinions. STS is a rare cancer that originates as an abnormal growth ...
GULFPORT, MS, UNITED STATES, February 27, 2026 /EINPresswire.com/ — Advances in clinical research continue to highlight the importance of accurately identifying ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results